Stockreport

Vor Bio to Participate in Upcoming Investor Conferences

Vor Biopharma Inc.  (VOR) 
PDF CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participa [Read more]